Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Du, Xin; Chen, Chun-yan; Weng, Jian-yu; Huang, Jian; Li, Fei; Zeng, Yun; Xiao, Zhen; Hu, Jian-da; Yang, Li-jie; Liu, Zhuo-gang; Li, Guo-hui; Sun, Xiu-li; Yang, Wei; Feng, Ru; Han, Yan-qiu; Jing, Yu; Xu, Na; Liu, Xiao-li; Liu, Zhen-fang; Wang, Xiao-dong; Wu, Shi-xin; Liang, Rong; Zhang, Yan-li; Yang, Yun-fan; Zhu, Huan-ling; Pan, Ling; Meng, Li; Zhao, Yan-hong; Yi, Hai; Liu, Yi-lan; Zhang, Wei-hua; Zheng, Yuan-jun; Zhou, Ze-ping; Chen, Su-ning

Science Citation Index Expanded

电子科技大学; 广东省人民医院; 北京大学; 华中科技大学; 吉林大学; 南昌大学; 南方医科大学; 山东大学; 内蒙古医学院; 哈尔滨医科大学; 河北医科大学; 四川大学; 浙江大学; 郑州大学; 苏州大学; 中国人民解放军第四军医大学; 中国医科大学; 中国医学科学院; 中国科学院; 中国医学科学院北京协和医院; 1

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

摘要

关键词